the company which specializes in

innovative stem cell therapies.

The company RHEACELL: our goal is to be the leader in the field of stem cell-based drugs

RHEACELL is a biopharmaceutical company dedicated to developing drugs based on a platform technology of ABCB5-positive (ABCB5+) mesenchymal stem cells.

Off-the shelf manufacturing process serving market needs

Worldwide exclusive patents with freedom to operate

Founding partners: a joint-venture between Müller und TICEBA

Key opinion leaders as partners for clinical research programs

our stem cells
points a way forward.


R&D is the key of our success. Specializing in stem cell-based drugs and taking this route from the outset has enabled us to bring quality and safety into a new research field.

Through our unique stem cell technology, we are bringing new healing opportunities to those who would otherwise have none. We are dedicated to developing drugs for those hitherto incurable serious chronic and hereditary diseases, which cannot be cured by conventional therapies.

Learn more

Clinical Research

Day in, day out, we passionately and resolutely work on innovative stem cell therapies for inflammatory and degenerative diseases. We discover new ways by researching in greater depth, thinking ahead, rechecking repeatedly and proving the knowledge we have gained from all over the world. For we know that research can only be as good as its implementation. The progress is solid only if it reaches patients via a systematic, rapid and safe pipeline. This is our conviction and our particular concern. Every Single Day.

© 2020 RHEACELL. All Rights Reserved.